14 Mar 2019 to 15 Mar 2019
The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
Don't miss the opportunity to meet one-to-one with CARB-X, Novo REPAIR Impact Fund, Roivant Sciences, Kurma Partners, Bacteriobator, Shionogi, Stonehaven Incubator, FIND Diagnostics, HEMEX, MSD, JPI AMR, GARDP, DZIF, European Investment Bank and more...
For more information click here.
